Furthermore, WB analysis of tumor tissues from different treatment groups revealed no significant differences in the expression of CAPRIN1, PD-L1, and CTLA-4 between the inhibitor NC + sh-NC group and the control group. The gene discussed is CAPRIN1; the disease is neoplasm.